What Alzamend Neuro Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 1 | 3 |
| Total trades | 1 | 3 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 2,000 | 7,184 |
| Net activity | −2,000 | −7,184 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Ault Milton C Iii | Director | Aug 26 | Open-market sale · S | −2,000 | $1.56 | −$3.12K | 0 |
| Ault Milton C Iii | Director | Dec 23 | Open-market sale · S | −1,851 | $2.07 | −$3.83K | 0 |
| Horne William B | Director | Dec 19 | Open-market sale · S | −3,333 | $2.12 | −$7.06K | 0 |
| McGrath Lynne Fahey | Director | Oct 23 | Open-market sale · S | −30 | $2.29 | −$68.7 | 25 |
| Ault Milton C Iii | Director | Oct 09 | Open-market sale · S | −20,397 | $2.32 | −$47.4K | 8,260 |
| Ault Milton C Iii | Director | Oct 08 | Open-market sale · S | −101,394 | $2.44 | −$247K | 28,657 |
| Ault Milton C Iii | Director | Oct 08 | Derivative Conversion · C | +61,743 | $2.32 | +$143K | 130,591 |
| Ault Milton C Iii | Director | Oct 07 | Open-market sale · S | −57,379 | $2.49 | −$143K | 68,848 |
| Ault Milton C Iii | Director | Oct 07 | Derivative Conversion · C | +100,000 | $2.32 | +$232K | 126,227 |
| Ault Milton C Iii | Director | Oct 06 | Open-market sale · S | −82,033 | $2.45 | −$201K | 26,227 |
| Ault Milton C Iii | Director | Oct 03 | Open-market sale · S | −65,903 | $2.44 | −$161K | 8,260 |
| Ault Milton C Iii | Director | Oct 03 | Derivative Conversion · C | +100,000 | $2.32 | +$232K | 108,260 |
| Ault Milton C Iii | Director | Oct 02 | Open-market sale · S | −20,686 | $2.39 | −$49.5K | 74,163 |
| Ault Milton C Iii | Director | Oct 01 | Open-market sale · S | −36,777 | $2.35 | −$86.4K | 94,849 |
| Ault Milton C Iii | Director | Oct 01 | Derivative Conversion · C | +100,000 | $2.32 | +$232K | 131,626 |
| Ault Milton C Iii | Director | Sep 30 | Open-market sale · S | −3,566 | $2.33 | −$8.32K | 31,626 |
| Ault Milton C Iii | Director | Sep 29 | Open-market sale · S | −38,324 | $2.31 | −$88.5K | 35,192 |
| Ault Milton C Iii | Director | Sep 26 | Open-market sale · S | −37,738 | $2.31 | −$87.3K | 73,516 |
| Ault Milton C Iii | Director | Sep 25 | Derivative Conversion · C | +100,000 | $2.32 | +$232K | 111,254 |
| Ault Milton C Iii | Director | Sep 25 | Open-market sale · S | −14,628 | $2.31 | −$33.8K | 11,254 |
Loading...